Epidiolex — United Healthcare

Initial criteria

• Diagnosis of Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex OR continuation of prior therapy for a seizure disorder

Reauthorization criteria

• Documentation of positive clinical response to therapy

Approval duration

12 months